《大行報告》麥格理:京東-SW(09618.HK)上季盈利勝市場預期 目標價輕微上調
麥格理發表報告指,京東-SW(09618.HK)第三季收入大致符合市場預期,盈利則超出市場預期,估計第四季收入按年增長4%,維持其「中性」評級,目標價由124元輕微上調至125元。
該行對於京東持保守態度,認為公司未有就穩定市場份額展示清晰路徑,在爭取用戶數量及保持盈利表現穩定之間,公司需要以關鍵策略推動財務表現提升。該行將公司2024及2025年收入預測,分別下調2%及3%,以反映對宏觀經濟看法保守,明年盈利預測維持不變,2025年則下調2%,認為公司要加快吸納用戶的步伐。(cy/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.